Relationship between periodontal disease and C-reactive protein among adults in the atherosclerosis risk in communities study

Archives of Internal Medicine

Volumn 163, Issue 10, 2003, Pages 1172-1179

  Slade, Gary D ^a,b   Ghezzi, Elisa M ^a,b   Heiss, Gerardo ^b,c   Beck, James D ^a,b   Riche, Estelle ^a   Offenbacher, Steven ^b  

^a North Carolina Oral Health Institute   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ACUTE PHASE RESPONSE; ADULT; AGE; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; BODY MASS; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; COMMUNITY; DIABETES MELLITUS; DRUG USE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENDER; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MOUTH EXAMINATION; MULTIVARIATE ANALYSIS; PERIODONTAL DISEASE; PRIORITY JOURNAL; RISK FACTOR;

ACUTE-PHASE REACTION; AGED; ARTERIOSCLEROSIS; BODY MASS INDEX; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIODONTAL DISEASES; REGRESSION ANALYSIS; RISK FACTORS; UNITED STATES;

EID: 0038582470     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.163.10.1172     Document Type: Article

References (34)

1. Ridker P, Cushman M, Stampfer M, Tracy R, Hennekens C. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973-979.
2. Richie RF, Whitley RJ. Section I: general clinical tests. In: Tietz NW, ed. Clinical Guide to Laboratory Tests. 2nd ed. Philadelphia, Pa: WB Saunders Co; 1990;166-167.
3. Palosuo T, Husman T, Koistinen J, Aho K. C-reactive protein in population samples. Acta Med Scand. 1986;220:175-179.
4. Macy EM, Hayes TE, Tracy RP. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem. 1997;43:52-58.
5. Tracy R, Lemaitre R, Psaty B, et al. Relation of C-reactive protein to risk of cardiovascular disease in the elderly. Arterioscler Thromb Vasc Biol. 1997;17:1121-1127.
6. Kuller L, Tracy R, Shaten J, Meilahn E. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol. 1996;144:537-547.
7. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation. 1998;98:731-733.
8. Koenig W, Sund M, Frohlich M, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. Circulation. 1999;99:237-242.
9. Mendall MA, Strachan DP, Butland BK, et al. C-reactive protein: Relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men. Eur Heart J. 2000;21:1584-1590.
10. Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med. 1994;331:417-424.
11. Biasucci LM, Liuzzo G, Grillo RL, et al. Elevated levels of C-reactive protein at discharge predict recurrent instability. Circulation. 1999;99:855-860.
12. Frohlich M, Imhof A, Berg G, et al. Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care. 2000;23:1835-1839.
13. Slade GD, Offenbacher S, Beck JD, Heiss G, Pankow JS. Acute-phase inflammatory response to periodontal disease in the US population. J Dent Res. 2000;79:49-57.
14. Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB, for the European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet. 1997;349:462-466.
15. Tracy RP, Psaty BM, Macy E, et al. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol. 1997;17:2167-2176.
16. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ. 1996;312:1061-1065.
17. Pirro M, Bergeron J, Dagenals GR, et al. Age and duration of follow-up as modulators of the risk for ischemic heart disease associated with high plasma C-reactive protein levels. Arch Intern Med. 2001;161:2474-2480.
18. Folsom AR, Aleksic N, Catellier D, Juneja HS, Wu KK. C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J. 2002;144:233-238.
19. Ebersole JL, Cappelli D. Acute-phase reactants in infections and inflammatory disease. Periodontology. 2000;23:19-49.
20. Beck JD, Offenbacher S. The association between periodontal diseases and cardiovascular diseases: a state-of-the-science review. Ann Periodontol. 2001;6:9-15.
21. Ebersole JL, Machen RL, Steffen MJ, Willman DE. Systemic acute-phase reactants, C-reactive protein and haptoglobin, in adult periodontitis. Clin Exp Immunol. 1997;107:347-352.
22. Wu T, Trevisan M, Genco RJ, et al. Examination of the relation between periodontal health status and cardiovascular risk factors: serum total and high density lipoprotein cholesterol, C-reactive protein, and plasma fibrinogen. Am J Epidemiol. 2000;151:273-282.
23. Hujoel PP, White BA, Garcia RI, Listgarten MA. The dentogingival epithelial surface area revisited. J Periodontal Res. 2001;36:48-55.
24. Offenbacher S. Periodontal diseases: pathogenesis. Ann Periodontol. 1996;1:821-878.
25. US Department of Health and Human Services. NHANES III Reference Manuals and Reports [book on CD-ROM]. Hyattsville, Md: National Center for Health Statistics; 1996.
26. ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol. 1989;129:687-702.
27. Papp AC, Hatzakis H, Bracey A, Wu KK. ARIC hemostasis study, I: development of a blood collection and processing system suitable for multicenter hemostatic studies. Thromb Haemost. 1989;61:15-19.
28. Imhof A, Froehlich M, Brenner H, et al. Effect of alcohol consumption on systemic markers of inflammation. Lancet. 2001;357:763-767.
29. Wener MH, Daum PR, McQuillan GM. The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration. J Rheumatol. 2000;27:2351-2359.
30. Carlos JP, Wolfe MD, Kingman A. The extent and severity index: a simple method for use in epidemiologic studies of periodontal disease. J Clin Periodontol. 1986;13:500-505.
31. Hak AE, Stehouwer CD, Bots ML, et al. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler Thromb Vasc Biol. 1999;19:1986-1991.
32. Katsuki A, Suminda Y, Murashim S, et al. Serum levels of tumor necrosis factor-α are increased in obese patients with non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1998;83:859-862.
33. Kuczmarski RJ, Carroll MD, Flegal KM, Troiano RP. Varying body mass index cutoff points to describe overweignt prevalence among US adults: NHANES III (1988 to 1994). Obes Res. 1997;5:542-548.
34. Hunt RJ, Fann SJ. Effect of examining half the teeth in a partial periodontal recording of older adults. J Oent Res. 1991;70:1380-1385.